Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Jun 2024 for Cara Therapeutics, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Susan Ph.D. Shiff: trading record in brief
All filings by Susan Ph.D. Shiff on record concern Tvardi Therapeutics, Inc., in the capacity of board member. Over a trading history stretching from 3 June 2021 to 4 June 2024, the count stands at 4 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 6 June 2024 came the latest disclosure, a share grant in Tvardi Therapeutics, Inc. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Susan Ph.D. Shiff
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
150,647 shares0Common StockSEC:0001415889-24-015756:0
32,362 shares0Common StockSEC:0001209191-23-034330:0
11,876 shares0Common StockSEC:0001209191-22-034627:0
7,200 shares0Common StockSEC:0001209191-21-038765:0
4 of 4 declarations
